Jessie Dorothy Trujillo

Title: Innovations of Jessie Dorothy Trujillo

Introduction

Jessie Dorothy Trujillo is a prominent inventor based in Manhattan, KS (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, her work focuses on creating effective solutions for influenza viruses.

Latest Patents

One of her latest patents is the Universal Mammalian Influenza Vaccine. This invention provides vaccine or immunogenic compositions comprising novel antigens derived from the equine strain of influenza H3N8. The proteins and specific immunogenic domains included in this vaccine are effective as primary universal influenza antigens. The disclosed vaccines or immunogenic compositions are highly effective in inducing HA specific antibodies that are reactive to different influenza viruses. They also promote mucosal and systemic immune responses, offering cross-protection regardless of influenza virus subtypes. In some embodiments, the vaccine is cross-protective against two or more subtypes of influenza, with or without the use of an adjuvant.

Career Highlights

Jessie is affiliated with the Iowa State University Research Foundation, Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the field of vaccine development.

Collaborations

Throughout her career, Jessie has collaborated with notable colleagues, including David Verhoeven and Brett Sponseller. These partnerships have enhanced her research and contributed to her success in the field.

Conclusion

Jessie Dorothy Trujillo's contributions to vaccine development, particularly her work on the Universal Mammalian Influenza Vaccine, highlight her innovative spirit and dedication to public health. Her achievements reflect the importance of research in combating infectious diseases.